Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
02/2001
02/13/2001US6187786 Antitumor and anticarcinogenic agents
02/13/2001US6187774 Fused heterocyclic compounds and pharmaceutical applications thereof
02/13/2001US6187770 N-substituted azaheterocyclic compounds
02/13/2001US6187757 Regulation of biological events using novel compounds
02/13/2001US6187568 Culture product of actinoplane; immunosuppressant, fungicides, antitumor agents
02/13/2001CA2001203C Novel antimicrobial dithiocarbamoyl quinolones
02/08/2001WO2001009190A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
02/08/2001WO2001009142A1 Oxazinocarbazoles for the treatment of cns diseases
02/08/2001WO2001009130A1 TRICYCLIC COMPOUNDS HAVING sPLA2-INHIBITORY ACTIVITIES
02/08/2001WO2001009119A2 Chemokine receptor antagonists
02/08/2001WO2000066590A3 Tetracyclic progesterone receptor modulator compounds and methods
02/08/2001CA2376927A1 Oxazinocarbazoles for the treatment of cns diseases
02/07/2001EP1074255A1 Medicinal compositions
02/07/2001EP1073662A1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives
02/07/2001EP1073661A1 Dioxazine derivatives and their use as dyestuffs
02/07/2001EP0789702B1 Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity
02/07/2001EP0789701B1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors
02/07/2001CN1283114A Benzoxazine compounds for enhancing synaptic response
02/07/2001CN1061658C Tricyclic benzazepine vasopression antagonists
02/07/2001CN1061652C Endotheliomycine receptor antagonist
02/06/2001US6184223 Reverse-turn mimetics and methods relating thereto
02/06/2001US6184217 Administering antiinflammatory dosage of a ring-substituted indolocarbazole derivative compound; tumor necrosis factor (tnf) inhibitors
02/01/2001WO2001007411A1 Biarylurea derivatives
02/01/2001WO2001007406A1 Novel amide derivatives
02/01/2001CA2380389A1 Biarylurea derivatives
01/2001
01/31/2001EP1071686A1 Novel heterocyclic compounds
01/31/2001CN1282332A Novel acronycine compounds, preparation method and pharmaceutical compositions containing them
01/31/2001CN1061351C Intermediates diaza or oxadiazabicyclic compounds
01/30/2001US6180411 Chromophore incorporating a photolabile group capable of undergoing an irreversible and detectable intramolecular transformation; chromophore is linked to binding site for analyte; for intracelluar analysis
01/25/2001WO2001005385A2 New use of a macrolide compound for treating neurodegenerative disorders
01/25/2001CA2379140A1 Use of a tacrolimus analogue as a neuroprotective agent
01/24/2001EP1070068A1 Granulatimide derivatives for use in cancer treatment
01/24/2001EP1070040A1 Oxidation process using periodic acid
01/24/2001EP1070039A1 Oxidation process using tempo
01/24/2001EP1069897A1 Methods for inhibiting mrp1
01/24/2001CN1281459A Piperidine derivatives
01/24/2001CN1281335A Treatment of schizophrenia with ampakines and neuroleptics
01/23/2001US6177572 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
01/23/2001US6177442 Bicyclic amine derivatives
01/23/2001US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
01/18/2001WO2001004125A1 Staurosporin derivatives
01/18/2001WO1999064049A9 Novel antibacterial agents
01/18/2001CA2379035A1 Staurosporin derivatives
01/17/2001EP1069132A1 Bicyclic derivatives of amino-pyrazinones, process of preparation and pharmaceutical compositions comprising them
01/17/2001EP1067935A1 Acylbenzoxazines for enhancing synaptic response(s)
01/17/2001EP1067932A1 Methods for inhibiting mrp1
01/17/2001EP1067928A1 Methods for inhibiting mrp1
01/17/2001EP0730590B1 isoxazoline and isoxazole fibrinogen receptor antagonists
01/17/2001EP0581959B1 Use of macrolide compounds for eye diseases
01/17/2001CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
01/16/2001US6174940 Synergistic stabilizer mixture based on polyalkyl-1-oxa-diazaspirodecane compounds
01/16/2001US6174915 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
01/16/2001US6174894 As insecticides, pesticides; for controlling acarine or nematode pests
01/11/2001WO2001002397A1 Tricyclic compounds having spiro union
01/11/2001WO2000043398A3 Tricyclic benzodiazepines as vasopressin receptor antagonists
01/10/2001EP1066039A1 Substituted quinazolines and analogs and the use thereof
01/10/2001EP1066035A2 Substituted aromatic compounds for treatment of antibiotic resistant infections
01/10/2001CN1279683A Method for producing f-methoxy-quinoline carboxylic acids
01/09/2001US6172235 Endothelian antagonist
01/09/2001US6172076 Inhibitors of prenyl-protein transferase
01/09/2001US6172074 Imidazopyridines and oxazolopyridines
01/04/2001WO2001000627A1 New indolocarbazole alkaloids from a marine actinomycete
01/04/2001WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
01/04/2001WO2001000210A1 Reverse-turn mimetics and methods relating thereto
01/04/2001WO2001000197A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
01/04/2001CA2376892A1 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
01/04/2001CA2375952A1 Reverse-turn mimetics and methods relating thereto
01/04/2001CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
01/03/2001EP1064942A1 Sustained release preparations
01/03/2001EP1064256A1 Bicyclo [2.2.1] heptanes and related compounds
01/03/2001CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals
01/03/2001CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity
01/03/2001CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors
01/03/2001CN1060168C Xanthene derivant, its preparation method and medicinal composition containing same
01/02/2001US6169188 Treating cyclooxygenase-2 mediated diseases
01/02/2001US6169086 Pyrazole derivatives
01/02/2001CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
01/02/2001CA2013449C Antibacterial 5-alkylquinolonecarboxylic acids
01/02/2001CA1341161C Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
12/2000
12/28/2000WO2000078881A2 Process for the preparation of herbicidal derivatives
12/28/2000WO2000078748A1 Quinoline derivatives as antibacterials
12/28/2000DE19911680A1 New extracts and compounds from Ganoderma pfeifferi , useful e.g. as antibacterial and antiviral agents, preservatives, cosmetic, pharmaceutical and food additives and in fish farming, are protease inhibitors
12/27/2000EP1062217A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
12/27/2000EP1062215A1 Antagonists of gonadotropin releasing hormone
12/27/2000CN1278264A Process for prepn. of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activity
12/27/2000CN1059905C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
12/26/2000US6166209 Piperidine derivatives
12/26/2000US6166010 For combating animal pests
12/26/2000US6166008 Treatment of schizophrenia with ampakines and neuroleptics
12/26/2000US6165944 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides
12/26/2000US6165787 Regulated transcription of targeted genes and other biological events
12/21/2000WO2000077010A2 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077004A1 1-azatricyclic-4-benzylpiperazines
12/21/2000WO2000077002A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077001A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2381322A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2375851A1 1-azatricyclic-4-benzylpiperazines
12/21/2000CA2374239A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373920A1 Substituted heterocycle fused gamma-carbolines
12/20/2000EP1059921A2 Use of macrolide compounds for the treatment of ards